Selected research
Industry Growth & Trends
Global C-X-C Chemokine Receptor Type 2 Industry Growth and Trends Forecast to 2032
Market perspective
According to APO Research, the global C-X-C Chemokine Receptor Type 2 market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.
The North America market for C-X-C Chemokine Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, corresponding to a CAGR of % over 2026-2032.
The Europe market for C-X-C Chemokine Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, registering a CAGR of % over 2026-2032.
Read the full market overview
The Asia Pacific market for C-X-C Chemokine Receptor Type 2 is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.
Leading global companies in the C-X-C Chemokine Receptor Type 2 market include ChemoCentryx Inc, Dompe Farmaceutici SpA, Syntrix Biosystems Inc, AstraZeneca Plc, GlaxoSmithKline Plc and Novartis AG, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.
Report Scope
This report provides a structured, data-driven view of the global C-X-C Chemokine Receptor Type 2 market, combining harmonized quantitative metrics with targeted qualitative insight to support business and growth strategy, market positioning, and capital allocation.
The C-X-C Chemokine Receptor Type 2 market size, estimates, and forecasts are presented in terms of revenue (US$ million), with 2025 as the base year and historical and forecast data for 2021-2032. The report segments the global C-X-C Chemokine Receptor Type 2 market by Type, Application, region/country, and company, provides regional market sizes at the segment level, profiles the competitive landscape and key players and their market ranks, and reviews technology trends and new product developments relevant to C-X-C Chemokine Receptor Type 2.
Key Companies & Market Share Insights
This section analyzes the strategies and performance of leading companies in the global C-X-C Chemokine Receptor Type 2 market, including portfolio focus, innovation and product development, mergers and acquisitions, collaborations, and geographic expansion used to sustain or enhance competitive positions. It also summarizes recent corporate developments and key financial indicators and provides global revenue and gross margin data by manufacturer for 2021-2026, enabling benchmarking of scale, profitability, and market share and supporting assessment of market concentration through indicators such as CR5 and CR10.
C-X-C Chemokine Receptor Type 2 Market by Company
ChemoCentryx Inc
Dompe Farmaceutici SpA
Syntrix Biosystems Inc
AstraZeneca Plc
GlaxoSmithKline Plc
Novartis AG
C-X-C Chemokine Receptor Type 2 Segment by Type
SX-517
PAC-G31P
DF-2755A
AZD-5069
Others
C-X-C Chemokine Receptor Type 2 Segment by Application
Prostate Cancer
Cornary Artery Disease
Liver Transplant Rejection
Pulmonary Inflammation
Others
C-X-C Chemokine Receptor Type 2 Segment by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Netherlands
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Southeast Asia
South America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Key Drivers & Barriers
High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.
Reasons to Buy This Report
1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global C-X-C Chemokine Receptor Type 2 market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of C-X-C Chemokine Receptor Type 2 and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of C-X-C Chemokine Receptor Type 2.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2021-2025, 2026-2031). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 3: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 4: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 5: Detailed analysis of C-X-C Chemokine Receptor Type 2 companies' competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 6: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter 7, 8, 9, 10 and 11: North America, Europe, Asia Pacific, South America, Middle East & Africa, revenue by country.
Chapter 12: Concluding Insights of the report
More report detail
Tables and figures
Scope & coverage.
Types
- SX-517
- PAC-G31P
- DF-2755A
- AZD-5069
- Others
Applications
- Prostate Cancer
- Cornary Artery Disease
- Liver Transplant Rejection
- Pulmonary Inflammation
- Others
Companies covered
- ChemoCentryx Inc
- Dompe Farmaceutici SpA
- Syntrix Biosystems Inc
- AstraZeneca Plc
- GlaxoSmithKline Plc
- Novartis AG
Inside the report.
1 Market Overview
- 1.1 Product Definition
- 1.2 Global Market Growth Prospects
- 1.3 Global C-X-C Chemokine Receptor Type 2 Market Size Overview by Region 2021 VS 2025 VS 2032
- 1.4 Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2021-2032)
- 1.4.1 Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2021-2026)
- 1.4.2 Global C-X-C Chemokine Receptor Type 2 Market Size by Region (2027-2032)
- 1.5 Key Regions C-X-C Chemokine Receptor Type 2 Market Size (2021-2032)
- 1.5.1 North America C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.2 Europe C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.4 South America C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (2021-2032)
- 1.5.5 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (2021-2032)
2 C-X-C Chemokine Receptor Type 2 Market by Type
- 2.1 Type Introduction
- 2.1.1 SX-517
- 2.1.2 PAC-G31P
- 2.1.3 DF-2755A
- 2.1.4 AZD-5069
- 2.1.5 Others
- 2.2 Global C-X-C Chemokine Receptor Type 2 Market Size by Type
- 2.2.1 Global C-X-C Chemokine Receptor Type 2 Market Size Overview by Type (2021-2032)
- 2.2.2 Global C-X-C Chemokine Receptor Type 2 Historic Market Size Review by Type (2021-2026)
- 2.2.3 Global C-X-C Chemokine Receptor Type 2 Market Size Forecasted by Type (2027-2032)
- 2.3 Global C-X-C Chemokine Receptor Type 2 Market Size by Regions
- 2.3.1 North America C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.2 Europe C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.4 South America C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Type (2021-2026)
- 2.3.5 Middle East and Africa C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Type (2021-2026)
3 C-X-C Chemokine Receptor Type 2 Market by Application
- 3.1 Type Introduction
- 3.1.1 Prostate Cancer
- 3.1.2 Cornary Artery Disease
- 3.1.3 Liver Transplant Rejection
- 3.1.4 Pulmonary Inflammation
- 3.1.5 Others
- 3.2 Global C-X-C Chemokine Receptor Type 2 Market Size by Application
- 3.2.1 Global C-X-C Chemokine Receptor Type 2 Market Size Overview by Application (2021-2032)
- 3.2.2 Global C-X-C Chemokine Receptor Type 2 Historic Market Size Review by Application (2021-2026)
- 3.2.3 Global C-X-C Chemokine Receptor Type 2 Market Size Forecasted by Application (2027-2032)
- 3.3 Global C-X-C Chemokine Receptor Type 2 Market Size by Regions
- 3.3.1 North America C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.2 Europe C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.4 South America C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Application (2021-2026)
- 3.3.5 Middle East and Africa C-X-C Chemokine Receptor Type 2 Market Size Breakdown by Application (2021-2026)
4 Global Market Dynamics
- 4.1 C-X-C Chemokine Receptor Type 2 Industry Trends
- 4.2 C-X-C Chemokine Receptor Type 2 Industry Drivers
- 4.3 C-X-C Chemokine Receptor Type 2 Industry Opportunities and Challenges
- 4.4 C-X-C Chemokine Receptor Type 2 Industry Restraints
5 Competitive Insights by Company
- 5.1 Global Top Players by C-X-C Chemokine Receptor Type 2 Revenue (2021-2026)
- 5.2 Global C-X-C Chemokine Receptor Type 2 Industry Company Ranking, 2024 VS 2025 VS 2026
- 5.3 Global C-X-C Chemokine Receptor Type 2 Key Company Headquarters & Area Served
- 5.4 Global C-X-C Chemokine Receptor Type 2 Company, Product Type & Application
- 5.5 Global C-X-C Chemokine Receptor Type 2 Company Commercialization Time
- 5.6 Market Competitive Analysis
- 5.6.1 Global C-X-C Chemokine Receptor Type 2 Market CR5 and HHI
- 5.6.2 Global Top 5 and 10 C-X-C Chemokine Receptor Type 2 Players Market Share by Revenue in 2025
- 5.6.3 2025 C-X-C Chemokine Receptor Type 2 Tier 1, Tier 2, and Tier 3
6 Company Profiles
- 6.1 ChemoCentryx Inc
- 6.1.1 ChemoCentryx Inc Company Information
- 6.1.2 ChemoCentryx Inc Business Overview
- 6.1.3 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.1.4 ChemoCentryx Inc C-X-C Chemokine Receptor Type 2 Product Portfolio
- 6.1.5 ChemoCentryx Inc Recent Developments
- 6.2 Dompe Farmaceutici SpA
- 6.2.1 Dompe Farmaceutici SpA Company Information
- 6.2.2 Dompe Farmaceutici SpA Business Overview
- 6.2.3 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.2.4 Dompe Farmaceutici SpA C-X-C Chemokine Receptor Type 2 Product Portfolio
- 6.2.5 Dompe Farmaceutici SpA Recent Developments
- 6.3 Syntrix Biosystems Inc
- 6.3.1 Syntrix Biosystems Inc Company Information
- 6.3.2 Syntrix Biosystems Inc Business Overview
- 6.3.3 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.3.4 Syntrix Biosystems Inc C-X-C Chemokine Receptor Type 2 Product Portfolio
- 6.3.5 Syntrix Biosystems Inc Recent Developments
- 6.4 AstraZeneca Plc
- 6.4.1 AstraZeneca Plc Company Information
- 6.4.2 AstraZeneca Plc Business Overview
- 6.4.3 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.4.4 AstraZeneca Plc C-X-C Chemokine Receptor Type 2 Product Portfolio
- 6.4.5 AstraZeneca Plc Recent Developments
- 6.5 GlaxoSmithKline Plc
- 6.5.1 GlaxoSmithKline Plc Company Information
- 6.5.2 GlaxoSmithKline Plc Business Overview
- 6.5.3 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.5.4 GlaxoSmithKline Plc C-X-C Chemokine Receptor Type 2 Product Portfolio
- 6.5.5 GlaxoSmithKline Plc Recent Developments
- 6.6 Novartis AG
- 6.6.1 Novartis AG Company Information
- 6.6.2 Novartis AG Business Overview
- 6.6.3 Novartis AG C-X-C Chemokine Receptor Type 2 Revenue, Global Share and Gross Margin (2021-2026)
- 6.6.4 Novartis AG C-X-C Chemokine Receptor Type 2 Product Portfolio
- 6.6.5 Novartis AG Recent Developments
7 North America
- 7.1 North America C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 7.2 North America C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
- 7.3 North America C-X-C Chemokine Receptor Type 2 Market Size Forecast by Country (2027-2032)
8 Europe
- 8.1 Europe C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 8.2 Europe C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
- 8.3 Europe C-X-C Chemokine Receptor Type 2 Market Size Forecast by Country (2027-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 9.2 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
- 9.3 Asia-Pacific C-X-C Chemokine Receptor Type 2 Market Size Forecast by Country (2027-2032)
10 South America
- 10.1 South America C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 10.2 South America C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
- 10.3 South America C-X-C Chemokine Receptor Type 2 Market Size Forecast by Country (2027-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size Growth Rate (CAGR) by Country: 2021 VS 2025 VS 2032
- 11.2 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size by Country (2021-2026)
- 11.3 Middle East & Africa C-X-C Chemokine Receptor Type 2 Market Size Forecast by Country (2027-2032)
12 Concluding Insights
13 Appendix
- 13.1 Reasons for Doing This Study
- 13.2 Research Methodology
- 13.3 Research Process
- 13.4 Authors List of This Report
- 13.5 Data Source
- 13.5.1 Secondary Sources
- 13.5.2 Primary Sources
GET THE RESEARCH
Choose your license.
Choose who needs access.
All options are for this report and research series.
PDF by email within 3–5 working days after payment confirmation.
Talk to an analyst